Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trialVolker Kunzmann, Wolfgang Blau, Jens T. Siveke et al.|The Lancet. Gastroenterology & hepatology|2020Cited by 202
Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era – analysis of the European LeukemiaNet Blast Phase RegistryAnnamaria Brioli, Michael Lauseker, Ulla Olsson‐Strömberg et al.|Leukemia|2024Cited by 25
Preinfection laboratory parameters may predict COVID‐19 severity in tumor patientsAlexander Kiani, Ralph Naumann, Romina Roesch et al.|Cancer Medicine|2021Cited by 6
Treatment and Disease Characteristics of Chronic Myeloid Leukemia in Blast Crisis: The European Leukemianet Blast Crisis RegistryAnnamaria Brioli, Michael Lauseker, Elza Lomaia et al.|Blood|2022Cited by 3